We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
New Study Points to Better Diagnostics for Cancer
News

New Study Points to Better Diagnostics for Cancer

New Study Points to Better Diagnostics for Cancer
News

New Study Points to Better Diagnostics for Cancer

Credit: Pixabay
Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "New Study Points to Better Diagnostics for Cancer"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

A new University of California, Irvine-led study finds a new method for identifying biomarkers may aid in early cancer diagnosis. The study focused on lung cancer, however the Cell Heterogeneity-Adjusted cLonal Methylation (CHALM) method has been tested on aging and Alzheimer's diseases as well and is expected to be effective for studying other diseases.

"We found the CHALM method may be a valuable tool in helping researchers to identify more reliable differentially methylated genes from sequence-based methylation data," said Wei Li, PhD, the Grace B. Bell chair and professor of bioinformatics in the Department of Biological Chemistry at the UCI School of Medicine. "For clinicians, this method may aid in cancer diagnosis by helping them identify more useful biomarkers, which are overlooked by the traditional method."

Published in Nature Communications, the study, titled, "Cellular Heterogeneity-Adjusted cLonal Methylation (CHALM) improves prediction of gene expression," illustrates the importance of considering cell heterogeneity when calculating the DNA methylation level from sequencing data.

"After applying our CHALM method to a lung cancer dataset, we were able to identify more reliable and biological functions-related differentially methylated genes. Applying our CHALM method may lead to better early cancer detection," said Li.

Using traditional methods for identifying cancer biomarkers, researchers have consistently found the correlation between gene expression and promoter methylation to be weak, especially for low methylated genes. This new study found the CHALM method allowed for more reliable identification of methylated markers that cannot be detected by traditional methods.

Reference: Xu J, Shi J, Cui X, et al. Cellular heterogeneity–adjusted clonal methylation (CHALM) improves prediction of gene expression. Nat Commun. 2021;12(1):400. doi:10.1038/s41467-020-20492-7

This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.

Advertisement